Literature DB >> 7850454

Lyophilization of biotechnology products.

A T Skrabanja1, A L de Meere, R A de Ruiter, P J van den Oetelaar.   

Abstract

In this review the lyophilization of biotechnology products is discussed. It is emphasized that the final quality of a protein product is determined by an interplay between the proper choice of excipients and the freeze-drying process. A crystalline matrix after freeze-drying is detrimental for the protein product. A glassy amorphous state is a prerequisite for stability, however a glassy state as such will not assure sufficient stability. The glass temperature which defines the state of the freeze-dried cake can be influenced by the moisture content and the choice of excipients.

Mesh:

Substances:

Year:  1994        PMID: 7850454

Source DB:  PubMed          Journal:  PDA J Pharm Sci Technol        ISSN: 1079-7440


  5 in total

1.  In-situ near-infrared spectroscopy monitoring of the lyophilization process.

Authors:  Mikael Brülls; Staffan Folestad; Anders Sparén; Anders Rasmuson
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

2.  Vacuum foam drying for preservation of LaSota virus: effect of additives.

Authors:  Sambhaji Pisal; Gopal Wawde; Shailendra Salvankar; Sanjay Lade; Shivajirao Kadam
Journal:  AAPS PharmSciTech       Date:  2006-07-21       Impact factor: 3.246

3.  Erythrosin B phosphorescence monitors molecular mobility and dynamic site heterogeneity in amorphous sucrose.

Authors:  Linda C Pravinata; Yumin You; Richard D Ludescher
Journal:  Biophys J       Date:  2005-02-04       Impact factor: 4.033

Review 4.  Application of bladder acellular matrix in urinary bladder regeneration: the state of the art and future directions.

Authors:  Marta Pokrywczynska; Iga Gubanska; Gerard Drewa; Tomasz Drewa
Journal:  Biomed Res Int       Date:  2015-02-22       Impact factor: 3.411

Review 5.  Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging.

Authors:  Silvia Franzé; Francesca Selmin; Elena Samaritani; Paola Minghetti; Francesco Cilurzo
Journal:  Pharmaceutics       Date:  2018-08-28       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.